 | Up a level |
Siegenthaler, M; Huynh-Do, Uyen; Krayenbuehl, P; Pollock, E; Widmer, U; Debaix, H; Olinger, E; Frank, M; Namdar, M; Ruschitzka, F; Nowak, A (2017). Impact of cardio-renal syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up. International journal of cardiology, 249, pp. 261-267. Elsevier 10.1016/j.ijcard.2017.09.027
Simic, B; Hermann, M; Shaw, SG; Bigler, L; Stalder, U; Dorries, C; Besler, C; Luscher, TF; Ruschitzka, F (2012). Torcetrapib impairs endothelial function in hypertension. European Heart Journal, 33(13), pp. 1615-1624. Oxford: Oxford University Press 10.1093/eurheartj/ehr348
Flammer, A.J.; T.Vo, N.T.; Ledergerber, B; Hermann, F; Gamperli, A; Huttner, A; Evison, J; Baumgartner, I; Cavassini, M; Hayoz, D.; Quitzau, K; Hersberger, M; Sudano, I; Ruschitzka, F; Luscher, T.F.; Noll, G; Weber, R. (2009). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial. Heart, 95(5), pp. 385-90. London: BMJ Publishing Group 10.1136/hrt.2007.137646
